UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA)

JACC. Cardiovascular interventions, 2020-01, Vol.13 (1), p.33-45

2020

Volltextzugriff (PDF)

[11C]PiB and [18F]AV45 PET radiotracers show different rates of amyloid‐β clearance

Alzheimer's & dementia, 2021-12, Vol.17 (S1), p.n/a

2021

Volltextzugriff (PDF)

Abstract P321: Is Amyloid Deposition in the Brain of Non-demented Older Adults a Consequence of High Blood Pressure and Arterial Stiffness?

Circulation (New York, N.Y.), 2013-03, Vol.127 (suppl_12)

2013

Volltextzugriff (PDF)

Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan

Brain (London, England : 1878), 2022-12, Vol.145 (12), p.4459-4473

2022

Volltextzugriff (PDF)

Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19

PLoS medicine, 2021-06, Vol.18 (6), p.e1003675-e1003675

2021

Volltextzugriff (PDF)

AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains

Alzheimer's & dementia, 2022-12, Vol.18 (S1), p.n/a

2022

Volltextzugriff (PDF)

AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains

Alzheimer's & dementia, 2022-12, Vol.18 (S4), p.n/a

2022

Volltextzugriff (PDF)

Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down syndrome

Alzheimer's & dementia, 2024-05, Vol.20 (5), p.3649-3656

2024

Volltextzugriff (PDF)

Age-related changes in the default mode network are more advanced in Alzheimer's disease

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S74-S75

2011

Volltextzugriff (PDF)

Age related changes in the default mode network are more advanced in Alzheimer's disease

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S738-S738

2011

Volltextzugriff (PDF)

Alternative Endpoints and Models for AD Prevention Trials

Alzheimer's & dementia, 2023-12, Vol.19 (S21), p.n/a

2023

Volltextzugriff (PDF)

ALZHEIMER DISEASE BIOMARKERS PREDICT DIFFERENCES IN PERSONALITY: A CROSS-LAGGED PANEL ANALYSIS

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P920-P921

2018

Volltextzugriff (PDF)

Amyloid Deposition and Hippocampal Volume as Predictors of Incident Dementia in Non-Demented Very Elderly Subjects (IN3-2.004)

Neurology, 2013-02, Vol.80 (7_supplement)

2013

Volltextzugriff (PDF)

Amyloid Deposition and Hippocampal Volume as Predictors of Incident Dementia in Non-Demented Very Elderly Subjects (S04.005)

Neurology, 2013-02, Vol.80 (7_supplement)

2013

Volltextzugriff (PDF)

Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old

Neurology, 2014-11, Vol.83 (20), p.1804-1811

2014

Volltextzugriff (PDF)

Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2018, Vol.10 (1), p.413-420

2018

Volltextzugriff (PDF)

Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease

Annals of neurology, 2022-11, Vol.92 (5), p.729-744

2022

Volltextzugriff (PDF)

Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study

Journal of Alzheimer's disease, 2015-09, Vol.48 Suppl 1 (s1), p.S151-S159

2015

Volltextzugriff (PDF)

"And Does That Necessarily Mean Absolutely Alzheimer's?" An Analysis of Questions Raised Following Amyloid PET Results Disclosure

The American journal of geriatric psychiatry, 2024-01, Vol.32 (1), p.45-54

2024

Volltextzugriff (PDF)

Antipsychotics Use in Parkinson Disease: Separating Appropriate Therapies from Treating Inappropriately

The American journal of geriatric psychiatry, 2017-07, Vol.25 (7), p.706-707

McDade, Eric Martin

2017

Volltextzugriff (PDF)

Antipsychotics Use in Parkinson's Disease: Separating Appropriate Therapies From Treating Inappropriately

The American journal of geriatric psychiatry, 2017

McDade, Eric Martin, DO

2017

Volltextzugriff (PDF)

Application of machine learning to predict amyloid, metabolic, and structural neuroimaging biomarkers in the progression of autosomal dominant Alzheimer disease

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

Application of machine learning to predict amyloid, metabolic, and structural neuroimaging biomarkers in the progression of autosomal dominant Alzheimer disease: Development of new models and analysis methods: Novel imaging analysis

Alzheimer's & dementia, 2020-12, Vol.16 (S2)

2020

Volltextzugriff (PDF)

1 – 25 von 423

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(414)
Mit Volltextzugriff
(380)

Publikationsform

Artikel
(422)
Berichte
(1)

Sprache

Englisch
(423)
Japanisch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(143)
Life Sciences & Biomedicine
(136)
Humans
(115)
Neurosciences & Neurology
(109)
Clinical Neurology
(89)
Neurology
(69)
Alzheimer's Disease
(66)
Female
(65)
Male
(65)
Neurosciences
(48)
Alzheimer Disease - Genetics
(47)
Adult
(45)
Middle Aged
(44)
Aged
(43)
Biomarkers
(38)
Alzheimer Disease - Diagnostic Imaging
(31)
Magnetic Resonance Imaging
(30)
Mutation
(30)
Dementia
(29)
Aged, 80 And Over
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA)

[11C]PiB and [18F]AV45 PET radiotracers show different rates of amyloid‐β clearance

Abstract P321: Is Amyloid Deposition in the Brain of Non-demented Older Adults a Consequence of High Blood Pressure and Arterial Stiffness?

Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan

Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19

AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains

AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains

Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down syndrome

Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease

Age-related changes in the default mode network are more advanced in Alzheimer's disease

Age related changes in the default mode network are more advanced in Alzheimer's disease

Alternative Endpoints and Models for AD Prevention Trials

ALZHEIMER DISEASE BIOMARKERS PREDICT DIFFERENCES IN PERSONALITY: A CROSS-LAGGED PANEL ANALYSIS

Amyloid Deposition and Hippocampal Volume as Predictors of Incident Dementia in Non-Demented Very Elderly Subjects (IN3-2.004)

Amyloid Deposition and Hippocampal Volume as Predictors of Incident Dementia in Non-Demented Very Elderly Subjects (S04.005)

Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old

Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure

Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease

Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study

"And Does That Necessarily Mean Absolutely Alzheimer's?" An Analysis of Questions Raised Following Amyloid PET Results Disclosure

Antipsychotics Use in Parkinson Disease: Separating Appropriate Therapies from Treating Inappropriately

Antipsychotics Use in Parkinson's Disease: Separating Appropriate Therapies From Treating Inappropriately

Application of machine learning to predict amyloid, metabolic, and structural neuroimaging biomarkers in the progression of autosomal dominant Alzheimer disease

Application of machine learning to predict amyloid, metabolic, and structural neuroimaging biomarkers in the progression of autosomal dominant Alzheimer disease: Development of new models and analysis methods: Novel imaging analysis

ARE WHITE MATTER HYPERINTENSITIES A CORE FEATURE OF ALZHEIMER’S DISEASE OR JUST A REFLECTION OF AMYLOID ANGIOPATHY? EVIDENCE FROM THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN)

Suchergebnisse filtern